West Pharmaceutical Services Outperforms Nasdaq With 32.7% YTD Gain
West Pharmaceutical Services leverages high-value biologic components and strong demand for self-injection platforms to outperform the broader market, securing a consensus Strong…
West Pharmaceutical Services leverages high-value biologic components and strong demand for self-injection platforms to outperform the broader market, securing a consensus Strong…
Cardinal Health shares remain supported by a 'Strong Buy' consensus and a $5 billion buyback expansion, even as the stock navigates recent…
Pediatrix posted strong adjusted earnings, but growth relies heavily on pricing and share repurchases as core patient volumes continue to slide.
Healthcare stocks like LLY, UNH, and JNJ provide tailored investment profiles for different age groups, balancing high-growth obesity drug pipelines with defensive…
Tenet Healthcare shares dropped 2.3% premarket as director Richard Mark offloaded 10,000 shares in a transaction valued at $2.63 million, leaving him…
CVS Health trades at an 11x forward P/E despite a strong Q2 earnings beat and raised 2026 guidance, leaving significant upside potential…
Congressional filings reveal new positions in Boston Scientific and Accenture, as BSX bulls argue the stock's 50% drop ignores strong core growth…
JNJ stock gains 1.3% as reports emerge of a potential $20 billion sale of its orthopedics unit to Apollo Global Management, a…
State Street's XLV and iShares' IXJ offer distinct paths for healthcare exposure, with XLV leading in cost efficiency and recent returns while…
Healthcare giants JNJ and MRK offer compelling long-term value through consistent dividend growth and strategic product diversification, positioning them as resilient assets…
Halozyme shares climb 59% this year as record-breaking Q2 earnings and aggressive institutional accumulation underscore the company's robust fundamental growth trajectory.
Tecsys posted record Q1 results fueled by healthcare sector expansion, prompting management to lift fiscal 2027 revenue and margin guidance as remaining…